Status:
TERMINATED
A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Influenza
Eligibility:
All Genders
18-64 years
Phase:
PHASE4
Brief Summary
This study will evaluate the efficacy and safety of Tamiflu in patients with clinically-diagnosed influenza occurring during an influenza outbreak within the community. Patients will be randomized to ...
Eligibility Criteria
Inclusion
- adult patients, 18-64 years of age;
- ambulatory;
- influenza-like illness;
- positive rapid assay for detection of influenza antigen.
Exclusion
- presentation \>36h after onset of symptoms;
- influenza-like symptoms outside an outbreak based on local surveillance activities;
- influenza vaccination between November 2006 and January 2007;
- receipt of antiviral therapy, systemic steroids or immunosuppressants within 2 weeks prior to study day 1.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00436124
Start Date
January 1 2007
End Date
April 1 2007
Last Update
February 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genova, Italy